Douglas Love is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently, Douglas holds positions as a Board Member for Sphinx Organization and Morehouse School of Medicine, as well as serving as the President and CEO of Annexon Biosciences. Previously, Douglas played a key role at Elan Pharmaceuticals as EVP, Head of Operations, Commercial and Alliance Management, and served in several leadership capacities, including VP and SVP of Business Integration and Business Development. Douglas began a legal career as Section Counsel at Genentech. Academically, Douglas earned a JD from the University of the Pacific - McGeorge School of Law, graduating in the top 10% of the class, and holds a BS in Business Administration from the University of Southern California.